Victor is a Special Advisor to Pappas Capital. He is also chairman of careLYFE and General Partner of venture capital firm Serica Partners. He previously served as CEO of Adicon Clinical Laboratories, a leading independent clinical laboratory in China, and President Asia Pacific of QIAGEN, a NASDAQ- and Frankfurt-listed leading company focused on in vitro diagnostics and life science research tools. Victor held senior positions at Aura Partners, Bridge Pharmaceuticals, Genospectra and Pappas Ventures. He was a faculty member at the National University of Singapore School of Medicine and a cancer research scientist at Merck & Co.
Victor is a Founding Director of BayHelix Group, a global association of Chinese life science business executives, and was elected Chairman from 2018 to 2019. He also serves on the Hong Kong Stock Exchange Biotech Advisory Committee.
University of Rochester (PhD)
University of Rochester (MS)
University of Science and Technology of China (BS)